Feb 8 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* ACQUIRES CLIA CERTIFICATE TO FACILITATE RAPID US MARKET
LAUNCH
WITH A SIGNIFICANTLY STRONGER FINANCIAL OUTLOOK
* BY HOLDING A CLIA CERTIFICATE, PROSTATYPE GENOMICS INC.
WILL BE
ABLE TO ACCEPT REIMBURSEMENT PAYMENTS FROM MEDICARE AND
COMMERCIAL PAYERS AND THEN UTILIZE ITS CLIA LABORATORY FOR
ANALYZING TESTS
Source text for Eikon: ID:nWkr4RvYhF
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))